National Centre for Foreign Animal Disease

Global and Regional Rare Disease Genetic Testing Market Analysis & Forecasts Report 2023-2033 - ResearchAndMarkets.com

Retrieved on: 
Monday, October 9, 2023
Health, Genetics, Diagnosis, Incidence, Parent, Hospital, DSM-IV codes, Physician, Exome, Plasma, Research, SRL Diagnostics, Genome, Prevalence, PCR, BGI Group, NGS, DNA, CVS, Risk, SNV calling from NGS data, Sanger, Massive parallel sequencing, Metabolism, Amniocentesis, Genetic code, Disease, State Key Laboratories, R, Inherit, Genomics, Patient, Polymerase chain reaction, WES, WGS, Genetic counseling, Growth, Genetic testing, Region, National Centre for Foreign Animal Disease, Gene, Rare, Chromosome, Fetus, Cardiogenic shock, Serum, Birth, Gastroenterology, Pharmaceutical industry, Medical imaging, Vaccine, Medical device, Dietary supplement

The "Rare Disease Genetic Testing Market - A Global and Regional Analysis: Focus on Disease Type, Offering, Specialty Type, Sample Type, Trait Type, Technology, Age Group, End User, and Country Analysis - Analysis and Forecast, 2023-2033" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Rare Disease Genetic Testing Market - A Global and Regional Analysis: Focus on Disease Type, Offering, Specialty Type, Sample Type, Trait Type, Technology, Age Group, End User, and Country Analysis - Analysis and Forecast, 2023-2033" report has been added to ResearchAndMarkets.com's offering.
  • The global market for rare disease genetic testing encompasses an array of panels and tests that excel in detecting rare diseases.
  • The global rare disease genetic testing market has experienced remarkable growth, driven by the escalating demand for early detection of rare diseases.
  • Moreover, a maximum number of rare disease testing is done there, due to which these regions hold the maximum share in the global rare disease genetic testing market.

Global and Regional Rare Disease Genetic Testing Market Report 2023-2033: Early Detection Demand and Innovative Systems Usher in New Era for Rare Disease Genetic Testing

Retrieved on: 
Tuesday, October 3, 2023
Chromosome, DNA, Sanger, National Centre for Foreign Animal Disease, Gastroenterology, Prevalence, BGI Group, DSM-IV codes, Serum, Disease, Fetus, Genomics, Parent, Hospital, Cardiogenic shock, SRL Diagnostics, NGS, Amniocentesis, CVS, Genetic testing, Research, Birth, Genetic code, Exome, Incidence, Genetic counseling, Plasma, Metabolism, Patient, Polymerase chain reaction, Physician, Risk, State Key Laboratories, WGS, Inherit, Growth, Diagnosis, Region, R, Rare, WES, SNV calling from NGS data, Massive parallel sequencing, Gene, PCR, Genome, Pharmaceutical industry, Medical imaging, Vaccine, Medical device, Dietary supplement

The global market for rare disease genetic testing encompasses an array of panels and tests that excel in detecting rare diseases.

Key Points: 
  • The global market for rare disease genetic testing encompasses an array of panels and tests that excel in detecting rare diseases.
  • Among the most prevalent rare disease genetic testing panels are those tailored for gastroenterology, endocrine and metabolic disorders, and neurological diseases.
  • The global rare disease genetic testing market has experienced remarkable growth, driven by the escalating demand for early detection of rare diseases.
  • Moreover, a maximum number of rare disease testing is done there, due to which these regions hold the maximum share in the global rare disease genetic testing market.

STATEMENT - Domestic dog tests positive for avian influenza in Canada

Retrieved on: 
Tuesday, April 4, 2023
Fox, Human, National Centre for Foreign Animal Disease, HPAI, Detection dog, Foreign animal disease, Public Health Agency of Canada, Mammal, Canadian Food Inspection Agency, Porpoise, Kathrin Glock, Respiratory system, World Health Organization, CFIA, WOAH, Government, Raccoon, Risk, Dog, Dolphin, Government of Canada, Health, Public Health Agency, Bird, Safety, Cat, Bottled water, Vaccine

The domestic dog was found to have been infected with avian influenza after chewing on a wild goose, and died after developing clinical signs.

Key Points: 
  • The domestic dog was found to have been infected with avian influenza after chewing on a wild goose, and died after developing clinical signs.
  • Based on the current evidence in Canada, the risk to the general public remains low and current scientific evidence suggests that the risk of a human contracting avian influenza from a domestic pet is minor.
  • Furthermore, no domestically acquired human cases of avian influenza have been reported in Canada.
  • We are tracking avian influenza activity in Canada and around the world, with domestic and international partners, including the World Health Organization.

Government of Canada announces up to $45.3 million to enhance African swine fever prevention and preparedness

Retrieved on: 
Friday, August 26, 2022
University, ASF, Pan-Canadian Framework on Clean Growth and Climate Change, Food, African swine fever virus, Airport, Disease, Research, Program, WOAH, Government, Sage Canaday, Canada Border Services Agency, Awareness, Global Framework Agreement, Vaccine, Agriculture and Agri-Food Canada, MB, Canadian Food Inspection Agency, Medicine, National Centre for Foreign Animal Disease, International Forum of Sovereign Wealth Funds, Dog, Foreign animal disease, FPT, Intelligence, Laboratory, The Honourable, Intention, Government of Canada, World Organisation for Animal Health, CBSA, Farm, Meat, Risk, Infection, Face, Industry, CFIA, Social media, Travel, Animal, Pig, Livestock, Drug, Medical device, Pharmaceutical industry, QC, Agriculture

To help ensure high levels of vigilance in the face of the threat of African swine fever, the Government of Canada is investing up to $23.4 million to support the pork industry's prevention and mitigation efforts.

Key Points: 
  • To help ensure high levels of vigilance in the face of the threat of African swine fever, the Government of Canada is investing up to $23.4 million to support the pork industry's prevention and mitigation efforts.
  • In addition, up to $19.8 million will be invested in the Canadian Food Inspection Agency's (CFIA) prevention and preparedness efforts.
  • Although Canada has never had a case of ASF, the disease continues to spread in several regions around the world.
  • "We must continue to work as a team - federal, provincial and territorial governments together with industry, to prevent African swine fever from entering the country.

Global Polymerase Chain Reactions (Standard, RT, Digital) Devices, Reagents and Uses Market Research Report 2022 - ResearchAndMarkets.com

Retrieved on: 
Friday, June 3, 2022
Chemicals, Plastics, Manufacturing, Polymerase chain reaction, DNA sequencing, World Health Organization, Polymerase, NGS, Digital polymerase chain reaction, Company, Infection, Siemens, QPCR, National Centre for Foreign Animal Disease, Organic acid, Becton, Dickinson and Company headquarters, World, Atlas, Real-time, Maintenance, Digital, Growth, Medical statistics, Hospital, DNA, Genetics, PCR, QIAGEN, Thermo Fisher Scientific, Prevalence, Country, Sanger sequencing, Agilent Technologies, CAGR, Bio-Rad Laboratories, Lithium, Fine chemical

The "Polymerase Chain Reactions (PCR) Devices, Reagents And Uses Global Market Report 2022" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Polymerase Chain Reactions (PCR) Devices, Reagents And Uses Global Market Report 2022" report has been added to ResearchAndMarkets.com's offering.
  • The Polymerase Chain Reactions (PCR) devices and reagents market consists of sales of PCR devices and reagents and related services.
  • Global Polymerase Chain Reactions (PCR) Devices, Reagents And Uses Market, Split By Region, Historic and Forecast, 2016-2019, 2023F, 2026F, 2031F, $ Billion
    5.2.
  • Global Polymerase Chain Reactions (PCR) Devices, Reagents And Uses Market, Split By Country, Historic and Forecast, 2016-2019, 2023F, 2026F, 2031F, $ Billion

The RCMP trials using satellite and hyperspectral aerial imaging to locate remains of missing persons

Retrieved on: 
Thursday, May 5, 2022
Hyperspectral imaging, National Research Council Canada, National Centre for Foreign Animal Disease, National, Collaboration, Agriculture and Agri-Food Canada, Soil, Missing, Eye, Sunlight, Partnership, RCMP, Program, Person, DNA, New York Academy of Art, Sensitive, Specialization, Technology, 3D, Medical imaging, Art

This is the first time that the RCMP is using hyperspectral imaging technologies in an attempt to locate human remains.

Key Points: 
  • This is the first time that the RCMP is using hyperspectral imaging technologies in an attempt to locate human remains.
  • There are currently just over 8,000 open missing persons and 760 open unidentified remains cases in the Missing Children/Persons Unidentified Remains Database.
  • The RCMP manages Canada's Missing, which is a public database of missing persons and unidentified remains.
  • In 2018, the RCMP created the National Missing Persons' DNA Program a collaboration between NCMPUR and the National DNA Databank.

Kelonia Therapeutics Launches with $50 Million Series A Financing to Pioneer Precision Targeted Genetic Medicines

Retrieved on: 
Thursday, April 28, 2022
Science, Biotechnology, Research, Pharmaceutical, Oncology, Health, FDA, Genetics, Antibody, Solution, Scientific method, Venrock, Associate, Massachusetts Institute of Technology, LinkedIn, Horizons Ventures, CGMP, CNRS, Twitter, Patient, Gene editing, Lymphatic system, FDA, RNA, Translation, Biological engineering, Therapy, Microbiology, CAR, Tissue, Neoplasm, Technology, Partnership, Series A round, Alta Partners, French National Centre for Scientific Research, Administered prices, Autoimmune disease, Stanford University, Hematological Cancer Research Investment and Education Act, Biology, Alta, Series, National Centre for Foreign Animal Disease, Toxic shock syndrome, Pharmaceutical industry, Vaccine, Management, Medicine, Kélonia, Research

Kelonia Therapeutics , a biotech company revolutionizing in vivo gene delivery, launched today with a $50 million Series A financing to usher in a new era of genetic medicines for a wide range of diseases.

Key Points: 
  • Kelonia Therapeutics , a biotech company revolutionizing in vivo gene delivery, launched today with a $50 million Series A financing to usher in a new era of genetic medicines for a wide range of diseases.
  • Kelonia is backed by a strong syndicate of investors with a track record of successfully launching and building disruptive biotech companies.
  • The companys early applications combine oncology-targeted therapeutics, such as CAR and T cell receptor molecules, with Kelonias precision in vivo targeting technology.
  • Kelonia is pioneering a new wave of genetic medicines using its next generation gene delivery platform.

Intertek Acucert is First Lab in India Accredited to ISO/IEC 17025:2017

Retrieved on: 
Tuesday, February 22, 2022
Health, Medical Devices, Technology, Supply Chain Management, Mobile, Wireless, Retail, Other Technology, Security, Certification, Malaysian Qualifications Agency, Dot, ISO/IEC, Inspection, Accreditation, ISO/IEC 17025, Telecom, Total, Wi-Fi, Common Criteria Testing Laboratory, National Centre for Foreign Animal Disease, National Accreditation Board for Testing and Calibration Laboratories, General manager, CCTL, Ministry, Government of India, Department of Telecommunications, Laboratory, Quality assurance, Total quality management, Communication, NCCS, CPE, Software, Calibration, Ministry of Electronics and Information Technology, Information technology, General officer, IOT, Electronics, Â, Department, NABL, Medical device, Intertek

This is the first ISO/IEC 17025:2017 certification issued in India, acknowledging that Acucert possesses the necessary expertise in software and IT system testing while meeting the rigorous quality control requirements of the standard.

Key Points: 
  • This is the first ISO/IEC 17025:2017 certification issued in India, acknowledging that Acucert possesses the necessary expertise in software and IT system testing while meeting the rigorous quality control requirements of the standard.
  • Accreditation to the standard enables the implementation of a laboratory quality system and demonstration of technical competence to produce reliable test results.
  • In achieving this prestigious accreditation, our Acucert lab is the first and only accredited software testing lab in India, commented Nitin Mishra, General Manager, Acucert.
  • Intertek Total Quality Assurance expertise, delivered consistently with precision, pace and passion, enabling our customers to power ahead safely.

First case of SARS-CoV-2 detected in Canadian wildlife

Retrieved on: 
Wednesday, December 1, 2021
Otter, Tissue, Parks Canada, Environment and Climate Change Canada, Mink, Ferret, Government of Canada, Public Health Agency of Canada, Deer, Severe acute respiratory syndrome coronavirus 2, World Organisation for Animal Health, National Centre for Foreign Animal Disease, Human, Public Health Agency, COVID-19, Animal, Environment, Lion, Research, Canadian Food Inspection Agency, OIE, Dog, Tiger, Government, Foreign animal disease, CFIA, ECCC, Cat, Hand, Disease, Oil, Hunting

Scientists in Canada and around the world are working hard to better understand the virus and its impacts on people, communities, and animals.

Key Points: 
  • Scientists in Canada and around the world are working hard to better understand the virus and its impacts on people, communities, and animals.
  • Environment and Climate Change Canada (ECCC), the Canadian Food Inspection Agency (CFIA), the Public Health Agency of Canada, Parks Canada, provincial and territorial governments, Canadian Wildlife Health Cooperative (CWHC), and academic partners have been proactively engaged in research to investigate whether SARS-CoV-2, the virus that causes COVID-19, has spilled into wildlife.
  • This finding emphasizes the importance of ongoing surveillance for SARS-CoV-2 in wildlife to increase our understanding about SARS-CoV-2 on the human-animal interface.
  • Federal, provincial and territorial partners continue to monitor and assess the potential implications of the virus on Canadian wildlife.

Comprehensive Glycoscience Encyclopedia Edition No. 2, 5 Volume Set (2021) - ResearchAndMarkets.com

Retrieved on: 
Thursday, November 25, 2021
Science, Health, Other Science, Other Health, Volume, National Centre for Foreign Animal Disease, University, University of Melbourne, French National Centre for Scientific Research, University of Alberta, Technology, Center, Research, Edition, CNRS, Interaction, Scientific method, Pharmaceutical industry

Comprehensive Glycoscience, Second Edition, Five Volume Set assembles the top minds in this area who provide an update on the renowned 2007 first edition, including new discoveries and latest advances in glycoscience-related research areas such as glycan microarrays, carbohydrate materials, glycoengineering and microbiome research.

Key Points: 
  • Comprehensive Glycoscience, Second Edition, Five Volume Set assembles the top minds in this area who provide an update on the renowned 2007 first edition, including new discoveries and latest advances in glycoscience-related research areas such as glycan microarrays, carbohydrate materials, glycoengineering and microbiome research.
  • The result is an up-to-date work which will impress readers with the many new advances that are outlined and taught in this second edition.
  • Introduction to Glycoscience, Glycan Structure and Function Joseph J. Barchi, Jr., Center for Cancer Research, Frederick, MD, USA
    2.
  • Glycans in Development, Health and Disease Professor Naoyuki Taniguchi, Osaka International Cancer Institute, Japan
    View source version on businesswire.com: https://www.businesswire.com/news/home/20211125006068/en/